Related references
Note: Only part of the references are listed.Proteomic and Mechanistic Analysis of Spironolactone in Patients at Risk for HF
Joao Pedro Ferreira et al.
JACC-HEART FAILURE (2021)
High-throughput targeted proteomics discovery approach and spontaneous reperfusion in ST-segment elevation myocardial infarction
Jay S. Shavadia et al.
AMERICAN HEART JOURNAL (2020)
Multiple Plasma Biomarkers for Risk Stratification in Patients With Heart Failure and Preserved Ejection Fraction
Julio A. Chirinos et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Temporal Patterns of 14 Blood Biomarker candidates of Cardiac Remodeling in Relation to Prognosis of Patients With Chronic Heart Failure-The Bio-SHiFT Study
Elke Bouwens et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2019)
Cysteine Cathepsins and Their Extracellular Roles: Shaping the Microenvironment
Eva Vidak et al.
CELLS (2019)
Sacubitril/Valsartan Decreases Cardiac Fibrosis in Left Ventricle Pressure Overload by Restoring PKG Signaling in Cardiac Fibroblasts
Ryan M. Burke et al.
CIRCULATION-HEART FAILURE (2019)
Biomarkers and Clinical Cardiovascular Outcomes With Ezetimibe in the IMPROVE-IT Trial
Arman Qamar et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Growth differentiation factor 15: A promising prognostic stratification biomarker in patients with acute coronary syndrome
Luxiang Shang et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2019)
Circulating proteins as predictors of incident heart failure in the elderly
Markus Stenemo et al.
EUROPEAN JOURNAL OF HEART FAILURE (2018)
Interleukin-1 blockade in cardiovascular diseases: a clinical update
Leo F. Buckley et al.
EUROPEAN HEART JOURNAL (2018)
Cysteine protease cathepsins in cardiovascular disease: from basic research to clinical trials
Cong-Lin Liu et al.
NATURE REVIEWS CARDIOLOGY (2018)
Increased Protein Tyrosine Phosphatase 1B (PTP1B) Activity and Cardiac Insulin Resistance Precede Mitochondrial and Contractile Dysfunction in Pressure-Overloaded Hearts
T. Dung Nguyen et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2018)
Identifying Pathophysiological Mechanisms in Heart Failure With Reduced Versus Preserved Ejection Fraction
Jasper Tromp et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
The Therapeutic Potential of Blocking Galectin-3 Expression in Acute Myocardial Infarction and Mitigating Inflammation of Infarct Region: A Clinical Outcome-Based Translational Study
Wassim Mosleh et al.
BIOMARKER INSIGHTS (2018)
Improved risk stratification of patients with acute coronary syndromes using a combination of hsTnT, NT-proBNP and hsCRP with the GRACE score
Roland Klingenberg et al.
EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE (2018)
Myocardial and Serum Galectin-3 Expression Dynamics Marks Post-Myocardial Infarction Cardiac Remodelling
Umesh C. Sharma et al.
HEART LUNG AND CIRCULATION (2017)
Effect of Losartan on Mitral Valve Changes After Myocardial Infarction
Philipp E. Bartko et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
The PCSK9-LDL Receptor Axis and Outcomes in Heart Failure BIOSTAT-CHF Subanalysis
Antoni Bayes-Genis et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
The Biological Basis for Cardiac Repair After Myocardial Infarction From Inflammation to Fibrosis
Sumanth D. Prabhu et al.
CIRCULATION RESEARCH (2016)
Multimarker Risk Stratification in Patients With Acute Myocardial Infarction
Michelle L. O'Donoghue et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)
Galectin-3 and post-myocardial infarction cardiac remodeling
Wouter C. Meijers et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
GRACE score predicts heart failure admission following acute coronary syndrome
David A. McAllister et al.
EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE (2015)
Protein Biomarkers of New-Onset Cardiovascular Disease Prospective Study From the Systems Approach to Biomarker Research in Cardiovascular Disease Initiative
Xiaoyan Yin et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2014)
Homogenous 96-Plex PEA Immunoassay Exhibiting High Sensitivity, Specificity, and Excellent Scalability
Erika Assarsson et al.
PLOS ONE (2014)
Osteoprotegerin in ST-elevation myocardial infarction: Prognostic impact and association with markers of myocardial damage by magnetic resonance imaging
Georg Fuernau et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Prognostic relevance of baseline pro- and anti-inflammatory markers in STEMI: An APEX AMI substudy
Sean van Diepen et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Plasma osteoprotegerin level on admission is associated with no-reflow phenomenon after primary angioplasty and subsequent left ventricular remodeling in patients with acute ST-segment elevation myocardial infarction
Ayhan Erkol et al.
ATHEROSCLEROSIS (2012)
Osteoprotegerin Predicts Long-Term Outcome in Patients with ST-Segment Elevation Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention
Sune Pedersen et al.
CARDIOLOGY (2012)
Osteoprotegerin and cardiovascular mortality in patients with non-ST elevation acute coronary syndromes
Ragnhild Roysland et al.
HEART (2012)
Growth Differentiation Factor-15 and Risk of Recurrent Events in Patients Stabilized After Acute Coronary Syndrome Observations From PROVE IT-TIMI 22
Marc P. Bonaca et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Osteoprotegerin Predicts Progression of Chronic Heart Failure: Results From CORONA
Thor Ueland et al.
CIRCULATION-HEART FAILURE (2011)
Elevated serum osteoprotegerin levels measured early after acute ST-elevation myocardial infarction predict final infarct size
Geir Oystein Andersen et al.
HEART (2011)
Thrombolysis in Myocardial Infarction (TIMI) Risk Index predicts long-term mortality and heart failure in patients with ST-elevation myocardial infarction in the TIMI 2 clinical trial
Quynh A. Truong et al.
AMERICAN HEART JOURNAL (2009)
Declining In-Hospital Mortality and Increasing Heart Failure Incidence in Elderly Patients With First Myocardial Infarction
Justin A. Ezekowitz et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Role of transforming growth factor-beta superfamily signaling pathways in human disease
Kelly J. Gordon et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2008)
Long-Term Trends in the Incidence of Heart Failure After Myocardial Infarction
Raghava S. Velagaleti et al.
CIRCULATION (2008)
Immediate mineralocorticoid receptor blockade improves myocardial infarct healing by modulation of the inflammatory response
Daniela Fraccarollo et al.
HYPERTENSION (2008)
Admission B-type natriuretic peptide assessment improves early risk stratification by Killip, classes and TIMI risk score in patients with acute ST elevation myocardial infarction treated with primary angioplasty
Marcin Grabowski et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2007)
Biomarkers of cardiovascular disease - Molecular basis and practical considerations
Ramachandran S. Vasan
CIRCULATION (2006)
Dysregulated osteoprotegerin/RANK ligand/RANK axis in clinical and experimental heart failure
T Ueland et al.
CIRCULATION (2005)
Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI): A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of pexelizumab in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention
PW Armstrong et al.
AMERICAN HEART JOURNAL (2005)
Increased collagen type I synthesis in patients with heart failure of hypertensive origin -: Relation to myocardial fibrosis
R Querejeta et al.
CIRCULATION (2004)
Predictors of hospital mortality in the global registry of acute coronary events
CB Granger et al.
ARCHIVES OF INTERNAL MEDICINE (2003)
Collagen accumulation after myocardial infarction:: effects of ETA receptor blockade and implications for early remodeling
D Fraccarollo et al.
CARDIOVASCULAR RESEARCH (2002)
TIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation - An intravenous nPA for treatment of infarcting myocardium early II trial substudy
DA Morrow et al.
CIRCULATION (2000)
Share Paper
